Skip to main content
Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease.
Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda.
Remuscularizing the Failing Human Heart.
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia.
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.
Corporate Vectors of Chronic Disease - Using Internal Industry Documents to Craft Counterstrategies.
Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk.
Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia.
Implications of Race Adjustment in Lung-Function Equations.
Exagamglogene Autotemcel for Severe Sickle Cell Disease.